Moderna COVID-19 vaccine waits for approval from Thai FDA


(FILES) In this file photo Dr. Nita Patel, Director of Antibody discovery and Vaccine development, lifts a vial with a potential coronavirus, COVID-19, vaccine at Novavax labs in Gaithersburg, Maryland on March 20, 2020, one of the labs developing a vaccine for the coronavirus, COVID-19. – The CEOs of nine companies developing vaccines against Covid-19 on September 8, 2020 pledged to “uphold the integrity of the scientific process” amid concern Donald Trump will pressure regulators to approve a vaccine ahead of the presidential election in November. “We, the undersigned biopharmaceutical companies, want to make clear our ongoing commitment to developing and testing potential vaccines for COVID-19 in accordance with high ethical standards and sound scientific principles,” said the CEOs.The statement was signed by AstraZeneca, BioNTech, GlaxoSmithKline, Johnson & Johnson, Merck, Moderna, Novavax, Pfizer and Sanofi. (Photo by ANDREW CABALLERO-REYNOLDS / AFP)

Thailand’s Public Health Ministry is looking to procure the Moderna COVID-19 vaccine through the Government Pharmaceutical Organization (GPO), after a discussion with a Moderna representative today.

The Moderna COVID-19 vaccine was developed in cooperation with the United States National Institute of Allergy and Infectious Diseases (NIAID) and the Biomedical Advanced Research and Development Authority (BARDA).

Thailand’s Public Health Minister, Anutin Charnvirakul, said that the ministry is ready to support Moderna’s registration with Thai FDA, after the company submitted the necessary documents, which the FDA confirms are complete. The Moderna vaccine could be approved within this month.

Moderna, however, said that the vaccine must be procured through governments, or agencies under government regulation only, meaning they cannot be purchased by the private sector directly.

Anutin said the ministry will assign the GPO to import the vaccines for private companies which confirm the amount they wish to order. He reiterated that the GPO cannot just stock up on vaccines and wait for them to be purchased.

Private companies can already order other vaccines, which have already been registered with FDA, namely AstraZeneca, Sinovac and Johnson & Johnson. There are 3 brands, Pfizer, Moderna and Sputnik V, waiting FDA approval.



Source link

Leave a Reply